Abstract:
본 발명은 진저레논 에이를 유효성분으로 함유하는 것을 특징으로 하는 비만 예방용 식품 조성물, 비만 치료용 약학 조성물 및 비만 치료용 동물 의약품에 관한 것으로, 지방 축적 억제 효과, 지방 세포로의 분화 시 발현되는 중요한 전사인자인 C/EBPα, PPARγ의 발현 저해 효과 및 FAS 발현 저해 효과를 발휘하는 진저레논 에이를 유효성분으로 함유하기 때문에 우수한 비만 예방 또는 치료 효과를 발휘한다.
Abstract translation:本发明涉及用于预防肥胖的食品组合物,用于治疗肥胖症的药物组合物和用于治疗肥胖症的动物药物,其含有作为有效成分的格那酮A作为有效成分,其中含有作为抑制脂肪蓄积的活性成分的格那酮A: C / EBPalpha和PPARgamma的表达是分化成脂肪细胞时表达的重要转录因子; 和FAS的表达,因此本发明对预防或治疗肥胖症具有优异的效果。
Abstract:
PURPOSE: An obesity prevention food composition containing gingerenone A, an obesity treating pharmaceutical composition, and an obesity treating composition for animals are provided to use a natural active material having an anti-obesity effect. CONSTITUTION: An obesity prevention food composition contains 0.000001-50wt% of gingerenone A. The obesity prevention food composition is a food material selected from the group consisting of meat, grains, caffeine drink, regular drink, chocolate, bread, snacks, cookies, pizza, jelly, noodles, gums, ice cream, alcoholic drink, vitamin compositions or other health assistant food. An obesity treating pharmaceutical composition is selected from a plaster, a granule, a lotion, a liniment, an ointment, a capsule, or pill, and other types of medical agents.
Abstract:
PURPOSE: An obesity prevention food composition containing hirsutenone, an obesity treating pharmaceutical composition, and an obesity treating composition for animals are provided to offer an anti-obesity effect of a natural active material. CONSTITUTION: An obesity prevention food composition contains 0.000001-50wt% of hirsutenone. An obesity treating pharmaceutical composition also contains 0.000001-50wt% of hirsutenone, and is selected from the group consisting of plasters, granules, lotions, liniments, aromatic water, powder, syrup, ophthalmic ointments, liquid solutions, aerosol, extracts, elixirs, emulsion, suspension, tablets, injections, and other types of medical agents. An obesity treating composition for animals also contain 0.000001-50wt% of hirsutenone.